United States Healthcare Equipment & Supplies

Heartflow Inc (HTFL)

Heartflow insiders executed forty sales totaling approximately 38.8 million dollars over the past ninety days. Key executives, including the CEO and CFO, offloaded shares following a strong 78.5% stock price rally. These divestments occurred after a positive August earnings report, reflecting systematic liquidation patterns rather than open market purchases.
Ticker: HTFL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Heartflow Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Rogers Campbell Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.98
Quantity 42,890 +45.3%
Value US$2,082,572
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
204.77
Quantity 62,092
Value US$1,266,040
Rogers Campbell Member of immediate family of any of the foregoing
Transaction date
Proposed sale
Price
303.09
Quantity 34,106
Value US$2,120,651
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
49.57
Quantity 38,900 -12.1%
Value US$1,928,195
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
49.57
Quantity 38,900
Value US$1,928,195
Rogers Campbell Chief Medical Officer Officer
Transaction date
Planned sale
Price
50.15
Quantity 19,682 -19.8%
Value US$987,052
Verghese Vikram Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.75
Quantity 16,766 -9.8%
Value US$850,926
Verghese Vikram Officer Officer
Transaction date
Proposed sale
Price
50.75
Quantity 16,766
Value US$850,927
Rogers Campbell Member of immediate family of any of the foregoing
Transaction date
Proposed sale
Price
50.15
Quantity 5,653
Value US$283,498
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
50.15
Quantity 19,682
Value US$987,052
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
50.15
Quantity 19,682
Value US$987,052
Verghese Vikram Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.11
Quantity 7,579 -4.2%
Value US$379,816
Verghese Vikram Officer Officer
Transaction date
Proposed sale
Price
50.11
Quantity 7,579
Value US$379,815
Verghese Vikram Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.01
Quantity 668 -0.4%
Value US$33,408
Verghese Vikram Officer Officer
Transaction date
Proposed sale
Price
50.01
Quantity 668
Value US$33,408
Verghese Vikram Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.24
Quantity 4,593 -2.5%
Value US$230,744
Verghese Vikram Officer Officer
Transaction date
Proposed sale
Price
50.24
Quantity 4,593
Value US$230,744
Verghese Vikram Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.06
Quantity 29,714 -13.9%
Value US$1,487,459
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 3,890 -1.2%
Value US$194,500
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
50.00
Quantity 3,890
Value US$194,500
Verghese Vikram Officer Officer
Transaction date
Proposed sale
Price
50.06
Quantity 29,714
Value US$1,487,460
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
46.42
Quantity 35,010 -9.7%
Value US$1,625,105
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
46.42
Quantity 35,010
Value US$1,625,104
Verghese Vikram Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.03
Quantity 6,640 -3.0%
Value US$332,212
Verghese Vikram Officer Officer
Transaction date
Proposed sale
Price
50.03
Quantity 6,640
Value US$332,212
Verghese Vikram Chief Financial Officer Officer
Transaction date
Planned sale
Price
49.69
Quantity 27,540 -11.1%
Value US$1,368,471
Verghese Vikram Officer Officer
Transaction date
Proposed sale
Price
49.69
Quantity 27,540
Value US$1,368,472
Verghese Vikram Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.60
Quantity 5,876 -2.3%
Value US$297,326
Verghese Vikram Officer Officer
Transaction date
Proposed sale
Price
50.60
Quantity 5,876
Value US$297,326
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 27,230 -7.0%
Value US$1,361,500
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
50.00
Quantity 27,230
Value US$1,361,500
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 32,676 -7.8%
Value US$1,470,420
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
45.00
Quantity 32,676
Value US$1,470,420
Rogers Campbell Chief Medical Officer Officer
Transaction date
Planned sale
Price
41.23
Quantity 9,219 -9.6%
Value US$380,099
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
41.23
Quantity 9,219
Value US$380,099
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
39.06
Quantity 15,560 -3.6%
Value US$607,774
Healey Joseph Patrick Affiliate of HCPCIV 1 LLC
Transaction date
Proposed sale
Price
41.50
Quantity 150,000
Value US$6,225,000
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
39.06
Quantity 15,560
Value US$607,774
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.31
Quantity 22,562 -4.9%
Value US$638,730
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.31
Quantity 22,562
Value US$638,730
Rogers Campbell Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.72
Quantity 9,219 -9.4%
Value US$237,113
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
25.72
Quantity 9,219
Value US$237,113
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.75
Quantity 22,562 -4.9%
Value US$626,096
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.75
Quantity 22,562
Value US$626,096
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.00
Quantity 38,900 -7.8%
Value US$1,361,500
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
35.00
Quantity 38,900
Value US$1,361,500
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.50
Quantity 22,562 -4.3%
Value US$643,017
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.50
Quantity 22,562
Value US$643,017
Rogers Campbell Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.34
Quantity 9,219 -10.5%
Value US$261,266
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
28.34
Quantity 9,219
Value US$261,266
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.12
Quantity 22,562 -4.2%
Value US$657,005
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
29.12
Quantity 22,562
Value US$657,005
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.72
Quantity 22,562 -3.9%
Value US$602,857
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
26.72
Quantity 22,562
Value US$602,857
Rogers Campbell Chief Medical Officer Officer
Transaction date
Planned sale
Price
24.64
Quantity 64,533 -44.3%
Value US$1,590,093
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
24.64
Quantity 64,533
Value US$1,589,935
Rogers Campbell Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.69
Quantity 64,533 -45.1%
Value US$1,658,033
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
25.69
Quantity 64,533
Value US$1,658,030
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 9,725 -1.7%
Value US$243,125
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
25.00
Quantity 9,725
Value US$243,125
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
22.66
Quantity 12,837 -2.2%
Value US$290,886
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
22.66
Quantity 12,837
Value US$290,886
3.2
Cullivan Julie A Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 9,122 -25.1%
Value US$228,050
3.2
Cullivan Julie A Director Non-Executive Director
Transaction date
Proposed sale
Price
25.00
Quantity 9,122
Value US$228,050
Rogers Campbell Chief Medical Officer Officer
Transaction date
Planned sale
Price
24.49
Quantity 65,153 -46.1%
Value US$1,595,486
Rogers Campbell Officer Officer
Transaction date
Proposed sale
Price
24.49
Quantity 65,153
Value US$1,595,485
Farquhar John C.M. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.46
Quantity 22,562 -3.7%
Value US$619,553
Farquhar John C.M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.46
Quantity 22,562
Value US$619,557
3.2
Cullivan Julie A Director Non-Executive Director
Transaction date
Proposed sale
Price
27.32
Quantity 8,000
Value US$218,560
3.2
Cullivan Julie A Non-Executive Director
Transaction date
Planned sale
Price
27.32
Quantity 8,000 -18.0%
Value US$218,560
3.2
Cullivan Julie A Director Non-Executive Director
Transaction date
Proposed sale
Price
27.32
Quantity 8,000
Value US$218,560
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-26 2026-10-22 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
42,890 +45.3%
20.98
US$2,082,572 		42,890 +45.3% 20.98 US$2,082,572
2026-10-22 2026-10-22 PrS Proposed sale
Rogers Campbell

Officer

Officer
62,092
204.77
US$1,266,040 		62,092 204.77 US$1,266,040
2026-10-22 2026-10-22 PrS Proposed sale
Rogers Campbell

Member of immediate family of any of the foregoing
34,106
303.09
US$2,120,651 		34,106 303.09 US$2,120,651
2026-10-14 2026-10-12 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
38,900 -12.1%
49.57
US$1,928,195 		38,900 -12.1% 49.57 US$1,928,195
2026-10-13 2026-10-12 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
38,900
49.57
US$1,928,195 		38,900 49.57 US$1,928,195
2026-09-21 2026-09-18 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
19,682 -19.8%
50.15
US$987,052 		19,682 -19.8% 50.15 US$987,052
2026-09-18 2026-09-18 PlS Planned sale
Verghese Vikram

Chief Financial Officer

Officer
16,766 -9.8%
50.75
US$850,926 		16,766 -9.8% 50.75 US$850,926
2026-09-18 2026-09-18 PrS Proposed sale
Verghese Vikram

Officer

Officer
16,766
50.75
US$850,927 		16,766 50.75 US$850,927
2026-09-18 2026-09-18 PrS Proposed sale
Rogers Campbell

Member of immediate family of any of the foregoing
5,653
50.15
US$283,498 		5,653 50.15 US$283,498
2026-09-18 2026-09-18 PrS Proposed sale
Rogers Campbell

Officer

Officer
19,682
50.15
US$987,052 		19,682 50.15 US$987,052
2026-09-18 2026-09-18 PrS Proposed sale
Rogers Campbell

Officer

Officer
19,682
50.15
US$987,052 		19,682 50.15 US$987,052
2026-09-18 2026-09-17 PlS Planned sale
Verghese Vikram

Chief Financial Officer

Officer
7,579 -4.2%
50.11
US$379,816 		7,579 -4.2% 50.11 US$379,816
2026-09-17 2026-09-17 PrS Proposed sale
Verghese Vikram

Officer

Officer
7,579
50.11
US$379,815 		7,579 50.11 US$379,815
2026-09-15 2026-09-15 PlS Planned sale
Verghese Vikram

Chief Financial Officer

Officer
668 -0.4%
50.01
US$33,408 		668 -0.4% 50.01 US$33,408
2026-09-15 2026-09-15 PrS Proposed sale
Verghese Vikram

Officer

Officer
668
50.01
US$33,408 		668 50.01 US$33,408
2026-09-15 2026-09-14 PlS Planned sale
Verghese Vikram

Chief Financial Officer

Officer
4,593 -2.5%
50.24
US$230,744 		4,593 -2.5% 50.24 US$230,744
2026-09-14 2026-09-14 PrS Proposed sale
Verghese Vikram

Officer

Officer
4,593
50.24
US$230,744 		4,593 50.24 US$230,744
2026-09-15 2026-09-11 PlS Planned sale
Verghese Vikram

Chief Financial Officer

Officer
29,714 -13.9%
50.06
US$1,487,459 		29,714 -13.9% 50.06 US$1,487,459
2026-09-14 2026-09-11 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
3,890 -1.2%
50.00
US$194,500 		3,890 -1.2% 50.00 US$194,500
2026-09-11 2026-09-11 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
3,890
50.00
US$194,500 		3,890 50.00 US$194,500
2026-09-11 2026-09-11 PrS Proposed sale
Verghese Vikram

Officer

Officer
29,714
50.06
US$1,487,460 		29,714 50.06 US$1,487,460
2026-09-14 2026-09-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
35,010 -9.7%
46.42
US$1,625,105 		35,010 -9.7% 46.42 US$1,625,105
2026-09-10 2026-09-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
35,010
46.42
US$1,625,104 		35,010 46.42 US$1,625,104
2026-09-10 2026-09-08 PlS Planned sale
Verghese Vikram

Chief Financial Officer

Officer
6,640 -3.0%
50.03
US$332,212 		6,640 -3.0% 50.03 US$332,212
2026-09-08 2026-09-08 PrS Proposed sale
Verghese Vikram

Officer

Officer
6,640
50.03
US$332,212 		6,640 50.03 US$332,212
2026-09-04 2026-09-03 PlS Planned sale
Verghese Vikram

Chief Financial Officer

Officer
27,540 -11.1%
49.69
US$1,368,471 		27,540 -11.1% 49.69 US$1,368,471
2026-09-03 2026-09-03 PrS Proposed sale
Verghese Vikram

Officer

Officer
27,540
49.69
US$1,368,472 		27,540 49.69 US$1,368,472
2026-09-04 2026-09-02 PlS Planned sale
Verghese Vikram

Chief Financial Officer

Officer
5,876 -2.3%
50.60
US$297,326 		5,876 -2.3% 50.60 US$297,326
2026-09-02 2026-09-02 PrS Proposed sale
Verghese Vikram

Officer

Officer
5,876
50.60
US$297,326 		5,876 50.60 US$297,326
2026-08-25 2026-08-21 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
27,230 -7.0%
50.00
US$1,361,500 		27,230 -7.0% 50.00 US$1,361,500
2026-08-21 2026-08-21 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
27,230
50.00
US$1,361,500 		27,230 50.00 US$1,361,500
2026-08-20 2026-08-18 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
32,676 -7.8%
45.00
US$1,470,420 		32,676 -7.8% 45.00 US$1,470,420
2026-08-18 2026-08-18 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
32,676
45.00
US$1,470,420 		32,676 45.00 US$1,470,420
2026-08-19 2026-08-17 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
9,219 -9.6%
41.23
US$380,099 		9,219 -9.6% 41.23 US$380,099
2026-08-17 2026-08-17 PrS Proposed sale
Rogers Campbell

Officer

Officer
9,219
41.23
US$380,099 		9,219 41.23 US$380,099
2026-08-18 2026-08-14 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
15,560 -3.6%
39.06
US$607,774 		15,560 -3.6% 39.06 US$607,774
2026-08-14 2026-08-14 PrS Proposed sale
Healey Joseph Patrick

Affiliate of HCPCIV 1 LLC
150,000
41.50
US$6,225,000 		150,000 41.50 US$6,225,000
2026-08-14 2026-08-14 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
15,560
39.06
US$607,774 		15,560 39.06 US$607,774
2026-08-12 2026-08-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -4.9%
28.31
US$638,730 		22,562 -4.9% 28.31 US$638,730
2026-08-10 2026-08-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
28.31
US$638,730 		22,562 28.31 US$638,730
2026-07-17 2026-07-15 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
9,219 -9.4%
25.72
US$237,113 		9,219 -9.4% 25.72 US$237,113
2026-07-15 2026-07-15 PrS Proposed sale
Rogers Campbell

Officer

Officer
9,219
25.72
US$237,113 		9,219 25.72 US$237,113
2026-07-13 2026-07-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -4.9%
27.75
US$626,096 		22,562 -4.9% 27.75 US$626,096
2026-07-10 2026-07-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
27.75
US$626,096 		22,562 27.75 US$626,096
2026-06-26 2026-06-24 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
38,900 -7.8%
35.00
US$1,361,500 		38,900 -7.8% 35.00 US$1,361,500
2026-06-24 2026-06-24 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
38,900
35.00
US$1,361,500 		38,900 35.00 US$1,361,500
2026-06-12 2026-06-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -4.3%
28.50
US$643,017 		22,562 -4.3% 28.50 US$643,017
2026-06-10 2026-06-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
28.50
US$643,017 		22,562 28.50 US$643,017
2026-05-20 2026-05-18 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
9,219 -10.5%
28.34
US$261,266 		9,219 -10.5% 28.34 US$261,266
2026-05-18 2026-05-18 PrS Proposed sale
Rogers Campbell

Officer

Officer
9,219
28.34
US$261,266 		9,219 28.34 US$261,266
2026-05-13 2026-05-11 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -4.2%
29.12
US$657,005 		22,562 -4.2% 29.12 US$657,005
2026-05-11 2026-05-11 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
29.12
US$657,005 		22,562 29.12 US$657,005
2026-04-30 2026-04-30 S Sale
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
56,224 -0.7%
30.05
US$1,689,531 		56,224 -0.7% 30.05 US$1,689,531
2026-04-30 2026-04-30 S Sale
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
892,533 -9.5%
29.18
US$26,044,113 		892,533 -9.5% 29.18 US$26,044,113
2026-04-30 2026-04-29 S Sale
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
797,133 -7.8%
29.37
US$23,411,796 		797,133 -7.8% 29.37 US$23,411,796
2026-04-30 2026-04-28 S Sale
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
254,110 -2.4%
30.51
US$7,752,896 		254,110 -2.4% 30.51 US$7,752,896
2026-04-14 2026-04-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -3.9%
26.72
US$602,857 		22,562 -3.9% 26.72 US$602,857
2026-04-10 2026-04-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
26.72
US$602,857 		22,562 26.72 US$602,857
2026-04-03 2026-04-01 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
64,533 -44.3%
24.64
US$1,590,093 		64,533 -44.3% 24.64 US$1,590,093
2026-04-01 2026-04-01 PrS Proposed sale
Rogers Campbell

Officer

Officer
64,533
24.64
US$1,589,935 		64,533 24.64 US$1,589,935
2026-03-23 2026-03-19 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
64,533 -45.1%
25.69
US$1,658,033 		64,533 -45.1% 25.69 US$1,658,033
2026-03-19 2026-03-19 PrS Proposed sale
Rogers Campbell

Officer

Officer
64,533
25.69
US$1,658,030 		64,533 25.69 US$1,658,030
2026-03-20 2026-03-18 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
9,725 -1.7%
25.00
US$243,125 		9,725 -1.7% 25.00 US$243,125
2026-03-18 2026-03-18 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
9,725
25.00
US$243,125 		9,725 25.00 US$243,125
2026-03-12 2026-03-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
12,837 -2.2%
22.66
US$290,886 		12,837 -2.2% 22.66 US$290,886
2026-03-10 2026-03-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
12,837
22.66
US$290,886 		12,837 22.66 US$290,886
2026-03-06 2026-03-05 PlS Planned sale
3.2
Cullivan Julie A
Non-Executive Director
9,122 -25.1%
25.00
US$228,050 		9,122 -25.1% 25.00 US$228,050
2026-03-05 2026-03-05 PrS Proposed sale
3.2
Cullivan Julie A

Director

Non-Executive Director
9,122
25.00
US$228,050 		9,122 25.00 US$228,050
2026-02-17 2026-02-12 PlS Planned sale
Rogers Campbell

Chief Medical Officer

Officer
65,153 -46.1%
24.49
US$1,595,486 		65,153 -46.1% 24.49 US$1,595,486
2026-02-12 2026-02-12 PrS Proposed sale
Rogers Campbell

Officer

Officer
65,153
24.49
US$1,595,485 		65,153 24.49 US$1,595,485
2026-02-10 2026-02-10 PlS Planned sale
Farquhar John C.M.

Chief Executive Officer

Executive Director
22,562 -3.7%
27.46
US$619,553 		22,562 -3.7% 27.46 US$619,553
2026-02-10 2026-02-10 PrS Proposed sale
Farquhar John C.M.

Officer; Director

Executive Director
22,562
27.46
US$619,557 		22,562 27.46 US$619,557
2026-02-12 2026-02-05 PrS Proposed sale
3.2
Cullivan Julie A

Director

Non-Executive Director
8,000
27.32
US$218,560 		8,000 27.32 US$218,560
2026-02-06 2026-02-05 PlS Planned sale
3.2
Cullivan Julie A
Non-Executive Director
8,000 -18.0%
27.32
US$218,560 		8,000 -18.0% 27.32 US$218,560
2026-02-05 2026-02-05 PrS Proposed sale
3.2
Cullivan Julie A

Director

Non-Executive Director
8,000
27.32
US$218,560 		8,000 27.32 US$218,560

See older Heartflow Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Heartflow Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Heartflow Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America